Sensitive detection of residual cancer cells following treatment through advanced molecular techniques. Provides early warning of disease recurrence in cancer patients.
Manufactured by
Guangdong Guangzhou, China
Burning Rock Dx (NASDAQ: BNR) is a global precision oncology leader specializing in NGS-based diagnostics for both tissue and liquid biopsy. With internationally accredited labs (CLIA, CAP, ISO15189, ISO13485) and deep NGS expertise, the company offers a broad portfolio of in-house assays and integrated solutions across the oncology development cycle. Burning Rock supports pharmaceutical development and decentralized clinical implementation, partnering with biopharma and clinical labs to advance trials, biomarker research, and real-world diagnostics. Key milestones include two NMPA-approved IVD kits, four CE-marked assays, and Breakthrough Device Designations from both the FDA and NMPA for its multi-cancer early detection test. Burning Rock is committed to transforming cancer care through innovative, science-driven solutions. In addition to the CLIA / CAP laboratory in the United States, we have a CLIA / CAP / ISO 15189 / ISO13485 lab in Guangzhou, China, which also obtained the technical certification of “High-throughput sequencing laboratory” issued by the Guangdong Center for Clinical Laboratory. We have passed over 200 inter-laboratory quality evaluations organized by NCCL, PQCC, EMQN, CAP, and other authoritative organizations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 3 relevant products
guangzhou biotron technolongy co.,ltd
China · 3 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 5 relevant products
Diatech Pharmacogenetics srl
Italy · 2 relevant products
Biopsense Oy
Finland · 2 relevant products
Nonacus
United Kingdom · 1 relevant product
Siemens Healthineers
United States · 2 relevant products
Lumigenex (Suzhou) Co., Ltd
China · 1 relevant product
FUJIFILM Healthcare Americas Corporation
United States · 1 relevant product
International Company for medical eq.
Egypt · 3 relevant products
52 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 93 closest product alternatives
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.
guangzhou biotron technolongy co.,ltd · China
Molecular diagnostic system tracking circulating tumor cell dynamics and nucleic acid markers to evaluate cancer treatment efficacy and guide therapeutic decisions.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A liquid biopsy-based test utilizing DNA methylation markers for post-treatment cancer recurrence monitoring and surveillance. Enables early detection of disease relapse and progression.
Diatech Pharmacogenetics srl · Italy
Molecular testing service for monitoring deep response in chronic myeloid leukemia patients from diagnosis through treatment follow-up. Utilizes genomic sequencing and variant analysis to track disease progression and treatment effectiveness.
Biopsense Oy · Finland
Blood-based diagnostic test for monitoring cancer treatment efficacy and detecting emerging drug resistance through analysis of circulating tumor DNA. Enables rapid treatment adjustment decisions based on genetic mutation detection in cfDNA.
guangzhou biotron technolongy co.,ltd · China
Liquid biopsy assay for real-time monitoring of circulating tumor markers and cells during perioperative periods to assess surgical outcomes and recurrence risk.
Nonacus · United Kingdom
Targeted sequencing panels designed for longitudinal patient monitoring and treatment response assessment. Enables detection of minimal residual disease and tracking of genomic changes over time to inform ongoing clinical management.
Siemens Healthineers · United States
Longitudinal monitoring solutions for chronic disease management and plasma cell disorder tracking, supporting continuous patient assessment and disease progression evaluation.
Siemens Healthineers · United States
Specialized testing solution for longitudinal monitoring of plasma cell disorders and chronic diseases. Provides consistent tracking of disease progression and therapeutic response.
Lumigenex (Suzhou) Co., Ltd · China
Diagnostic test designed for chronic disease monitoring and management. Enables regular assessment of disease markers to guide ongoing patient treatment.
FUJIFILM Healthcare Americas Corporation · United States
Diagnostic testing solutions for continuous monitoring of chronic disease progression and management. Enables healthcare providers to track patient health status and treatment efficacy over time.
International Company for medical eq. · Egypt
Diagnostic testing to measure medication levels in patient blood samples.
81 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products